Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 26
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Mammographic density and breast cancer in women from high risk families

  • Ramón Y Cajal, Teresa
  • Chirivella, Isabel
  • Miranda, Josefa
  • Teule, Alexandre
  • Izquierdo, Angel
  • Balmaña, Judith
  • Sánchez-Heras, Ana Beatriz
  • Llort, Gemma
  • Fisas, David
  • Lope Carvajal, Virginia
  • Hernandez-Agudo, Elena
  • Juan-Fita, María José
  • Tena, Isabel
  • Robles, Luis
  • Guillén-Ponce, Carmen
  • Pérez-Segura, Pedro
  • Luque-Molina, Mari Sol
  • Hernando-Polo, Susana
  • Salinas, Mónica
  • Brunet, Joan
  • Salas-Trejo, Dolores
  • Barnadas, Agustí
  • Pollan-Santamaria, Marina
INTRODUCTION: Mammographic density (MD) is one of the strongest determinants of sporadic breast cancer (BC). In this study, we compared MD in BRCA1/2 mutation carriers and non-carriers from BRCA1/2 mutation-positive families and investigated the association between MD and BC among BRCA1/2 mutation carriers per type of mutation and tumor subtype. METHODS: The study was carried out in 1039 female members of BRCA1 and BRCA2 mutation-positive families followed at 16 Spanish Genetic Counseling Units. Participants' density was scored retrospectively from available mammograms by a single blinded radiologist using a 5-category scale (<10 %, 10-25 %, 25-50 %, 50-75 %, >75 %). In BC cases, we selected mammograms taken prior to diagnosis or from the contralateral breast, whereas, in non-cases, the last screening mammogram was evaluated. MD distribution in carriers and non-carriers was compared using ordinal logistic models, and the association between MD and BC in BRCA1/2 mutation carriers was studied using logistic regression. Huber-White robust estimators of variance were used to take into account correlations between family members. A similar multinomial model was used to explore this association by BC subtype. RESULTS: We identified and scored mammograms from 341 BRCA1, 350 BRCA2 mutation carriers and 229 non-carriers. Compared to non-carriers, MD was significantly lower among BRCA2 mutation carriers (odds ratio (OR) =0.71; P-value=0.04), but not among BRCA1 carriers (OR=0.84; P-value=0.33). MD was associated with subsequent development BC (OR per category of MD=1.45; 95 % confidence interval=1.18-1.78, P-value<0.001), with no significant differences between BRCA1 and BRCA2 mutation carriers (P-value=0.48). Finally, no statistically significant differences were observed in the association of MD with specific BC subtypes. CONCLUSIONS: Our study, the largest to date on this issue, confirms that MD is an independent risk factor for all BC subtypes in either BRCA1 and BRCA2 mutation carriers, and should be considered a phenotype risk marker in this context.
Repisalud
Publicación Artículo científico (JournalArticle)

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

  • Lecarpentier, Julie
  • Silvestri, Valentina
  • Kuchenbaecker, Karoline B
  • Barrowdale, Daniel
  • Dennis, Joe
  • McGuffog, Lesley
  • Soucy, Penny
  • Leslie, Goska
  • Rizzolo, Piera
  • Navazio, Anna Sara
  • Valentini, Virginia
  • Zelli, Veronica
  • Lee, Andrew
  • Amin Al Olama, Ali
  • Tyrer, Jonathan P
  • Southey, Melissa
  • John, Esther M
  • Conner, Thomas A
  • Goldgar, David E
  • Buys, Saundra S
  • Janavicius, Ramunas
  • Steele, Linda
  • Ding, Yuan Chun
  • Neuhausen, Susan L
  • Hansen, Thomas V O
  • Osorio, Ana
  • Weitzel, Jeffrey N
  • Toss, Angela
  • Medici, Veronica
  • Cortesi, Laura
  • Zanna, Ines
  • Palli, Domenico
  • Radice, Paolo
  • Manoukian, Siranoush
  • Peissel, Bernard
  • Azzollini, Jacopo
  • Viel, Alessandra
  • Cini, Giulia
  • Damante, Giuseppe
  • Tommasi, Stefania
  • Peterlongo, Paolo
  • Fostira, Florentia
  • Hamann, Ute
  • Evans, D Gareth
  • Henderson, Alex
  • Brewer, Carole
  • Eccles, Diana
  • Cook, Jackie
  • Ong, Kai-Ren
  • Walker, Lisa
  • Side, Lucy E
  • Porteous, Mary E
  • Davidson, Rosemarie
  • Hodgson, Shirley
  • Frost, Debra
  • Adlard, Julian
  • Izatt, Louise
  • Eeles, Ros
  • Ellis, Steve
  • Tischkowitz, Marc
  • Godwin, Andrew K
  • Meindl, Alfons
  • Gehrig, Andrea
  • Dworniczak, Bernd
  • Sutter, Christian
  • Engel, Christoph
  • Niederacher, Dieter
  • Steinemann, Doris
  • Hahnen, Eric
  • Hauke, Jan
  • Rhiem, Kerstin
  • Kast, Karin
  • Arnold, Norbert
  • Ditsch, Nina
  • Wang-Gohrke, Shan
  • Wappenschmidt, Barbara
  • Wand, Dorothea
  • Lasset, Christine
  • Stoppa-Lyonnet, Dominique
  • Belotti, Muriel
  • Damiola, Francesca
  • Barjhoux, Laure
  • Mazoyer, Sylvie
  • Van Heetvelde, Mattias
  • Poppe, Bruce
  • De Leeneer, Kim
  • Claes, Kathleen B M
  • de la Hoya, Miguel
  • Garcia-Barberan, Vanesa
  • Caldes, Trinidad
  • Perez Segura, Pedro
  • Kiiski, Johanna I
  • Aittomäki, Kristiina
  • Khan, Sofia
  • Nevanlinna, Heli
  • van Asperen, Christi J
  • Vaszko, Tibor
  • Kasler, Miklos
  • Olah, Edith
  • Balmaña, Judith
  • Gutiérrez-Enríquez, Sara
  • Diez, Orland
  • Teulé, Alex
  • Izquierdo, Angel
  • Darder, Esther
  • Brunet, Joan
  • Del Valle, Jesús
  • Feliubadalo, Lidia
  • Pujana, Miquel Angel
  • Lazaro, Conxi
  • Arason, Adalgeir
  • Agnarsson, Bjarni A
  • Johannsson, Oskar Th
  • Barkardottir, Rosa B
  • Alducci, Elisa
  • Tognazzo, Silvia
  • Montagna, Marco
  • Teixeira, Manuel R
  • Pinto, Pedro
  • Spurdle, Amanda B
  • Holland, Helene
  • Lee, Jong Won
  • Lee, Min Hyuk
  • Lee, Jihyoun
  • Kim, Sung-Won
  • Kang, Eunyoung
  • Kim, Zisun
  • Sharma, Priyanka
  • Rebbeck, Timothy R
  • Vijai, Joseph
  • Robson, Mark
  • Lincoln, Anne
  • Musinsky, Jacob
  • Gaddam, Pragna
  • Tan, Yen Y
  • Berger, Andreas
  • Singer, Christian F
  • Loud, Jennifer T
  • Greene, Mark H
  • Mulligan, Anna Marie
  • Glendon, Gord
  • Andrulis, Irene L
  • Toland, Amanda Ewart
  • Senter, Leigha
  • Bojesen, Anders
  • Nielsen, Henriette Roed
  • Skytte, Anne-Bine
  • Sunde, Lone
  • Jensen, Uffe Birk
  • Pedersen, Inge Sokilde
  • Krogh, Lotte
  • Kruse, Torben A
  • Caligo, Maria A
  • Yoon, Sook-Yee
  • Teo, Soo-Hwang
  • von Wachenfeldt, Anna
  • Huo, Dezheng
  • Nielsen, Sarah M
  • Olopade, Olufunmilayo I
  • Nathanson, Katherine L
  • Domchek, Susan M
  • Lorenchick, Christa
  • Jankowitz, Rachel C
  • Campbell, Ian
  • James, Paul
  • Mitchell, Gillian
  • Orr, Nick
  • Park, Sue Kyung
  • Thomassen, Mads
  • Offit, Kenneth
  • Couch, Fergus J
  • Simard, Jacques
  • Easton, Douglas F
  • Chenevix-Trench, Georgia
  • Schmutzler, Rita K
  • Antoniou, Antonis C
  • Ottini, Laura
Purpose BRCA1/2 mutations increase the risk of breast and prostate cancer in men. Common genetic variants modify cancer risks for female carriers of BRCA1/2 mutations. We investigated-for the first time to our knowledge-associations of common genetic variants with breast and prostate cancer risks for male carriers of BRCA1/ 2 mutations and implications for cancer risk prediction. Materials and Methods We genotyped 1,802 male carriers of BRCA1/2 mutations from the Consortium of Investigators of Modifiers of BRCA1/2 by using the custom Illumina OncoArray. We investigated the combined effects of established breast and prostate cancer susceptibility variants on cancer risks for male carriers of BRCA1/2 mutations by constructing weighted polygenic risk scores (PRSs) using published effect estimates as weights. Results In male carriers of BRCA1/2 mutations, PRS that was based on 88 female breast cancer susceptibility variants was associated with breast cancer risk (odds ratio per standard deviation of PRS, 1.36; 95% CI, 1.19 to 1.56; P = 8.6 × 10-6). Similarly, PRS that was based on 103 prostate cancer susceptibility variants was associated with prostate cancer risk (odds ratio per SD of PRS, 1.56; 95% CI, 1.35 to 1.81; P = 3.2 × 10-9). Large differences in absolute cancer risks were observed at the extremes of the PRS distribution. For example, prostate cancer risk by age 80 years at the 5th and 95th percentiles of the PRS varies from 7% to 26% for carriers of BRCA1 mutations and from 19% to 61% for carriers of BRCA2 mutations, respectively. Conclusion PRSs may provide informative cancer risk stratification for male carriers of BRCA1/2 mutations that might enable these men and their physicians to make informed decisions on the type and timing of breast and prostate cancer risk management.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Near-surface defects break symmetry in water adsorption on CeO2x(111)

  • Custance, Oscar
  • Gonzalez Lastre, Manuel
  • Kim, Kyungmin
  • Fernández-Villanueva, Estefanía
  • Pou, Pablo
  • Abe, Masayuki
  • Sepehri-Amin, Hossein
  • Kawai, Shigeki
  • Ganduglia-Pirovano, M. Veronica
  • Perez, Ruben
[EN] Water interactions with oxygen-deficient cerium dioxide (CeO2) surfaces are central to hydrogen production and catalytic redox reactions, but the atomic-scale details of how defects influence adsorption and reactivity remain elusive. Here, we unveil how water adsorbs on partially reduced CeO2-x(111) using atomic force microscopy (AFM) with chemically sensitive, oxygen-terminated probes, combined with first-principles calculations. Our AFM imaging reveals water molecules as sharp, asymmetric boomerang-like features radically departing from the symmetric triangular motifs previously attributed to molecular water. Strikingly, these features localize near subsurface defects. While the experiments are carried out at cryogenic temperatures, water was dosed at room temperature, capturing configurations relevant to initial adsorption events in catalytic processes. Density functional theory identifies Ce3+ sites adjacent to subsurface vacancies as the thermodynamically favored adsorption sites, where defect-induced symmetry breaking governs water orientation. Force spectroscopy and simulations further distinguish Ce3+ from Ce4+ centers through their unique interaction signatures. By resolving how subsurface defects control water adsorption at the atomic scale, this work demonstrates the power of chemically selective AFM for probing site-specific reactivity in oxide catalysts, laying the groundwork for direct investigations of complex systems such as single-atom catalysts, metal-support interfaces, and defect-engineered oxides., This work was supported by NIMS grants (AG2030 and AM2100), by several Grant-in-Aid for Scientific Research (19H05789, 21H01812, 21K18876, 22H00285, 23KJ1516, 24K01350) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and by the Spanish Ministry of Science, Innovation and Universities (MCIU), through projects PID2023-149150OB-I00 and PID2021-128915NB-I00, and the "Maria de Maeztu" Program for Units of Excellence in R&D (CEX2023-001316-M). E.F.V. acknowledges support from the Margarita Salas postdoctoral fellowship (Spanish MIU and European Union NextGenerationEU) and the MOMENTUM Program (MMT-24-ICP-01, Plan de Recuperacion, Transformacion y Resiliencia European Union NextGenerationEU). The Spanish Supercomputing Network (RES) is acknowledged for providing computational resources at the Marenostrum Supercomputer (BSC, Barcelona).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

MC3T3-E1 cell response to microporous tantalum oxide surfaces enriched with Ca, P and Mg

  • Alves, C. F. Almeida
  • Fialho, L.
  • Marques, S. M.
  • Pires, S.
  • Palacio, C.
  • Carvalho, S.
  • Rico Tortosa, Patricia María
[EN] The formation of a porous oxide surface doped with osteoconductive elements, Ca, P and Mg, to enhance osseointegration, was achieved through micro arc oxidation. Micro arc oxidation parameters, such as electrolyte composition, concentration and applied voltage, were studied to understand their effect on the morphology and chemical composition of the samples surface.& nbsp; Considering the optimum atomic concentration reported in literature for each osteoconductive element, microporous Ta anodic oxide samples treated with calcium acetate (CaA) and 13-glycerophosphate (13-GP) revealed that an increase of 13-GP molarity in the electrolyte boosts Ca incorporation, as well as, increasing the porosity. In adding magnesium acetate (MgA) to the electrolyte, when composed by CaA + 13-GP, both addition and variation of MgA did not affect the surface morphology along the samples, being incorporated into the oxide layer for 0.1 M.& nbsp; Finally, in vitro tests were carried out to study the biocompatibility of Ta, to verify the cytotoxicity of the samples and their behavior towards cells, by performing adhesion and differentiation tests with the MC3T3-E1 cell line. Cytotoxicity tests revealed that the samples were non-toxic. Despite none of the samples having been raised up through cell adhesion tests, cell differentiation revealed promising results for the Ta-CaP., This research is sponsored by FEDER funds through the program COMPETE -Programa Operacional Factores de Competitividade and by the Portuguese Foundation for Science and Technology (FCT) in the framework of the Strategic Funding UIDB/04650/2020, and UID/EMS/00285/2020 and with a PhD fellowship SFRH/BD/98199/2013. The authors also thank the financial support in the framework of HEALTHYDENT -POCI-01-0145-FEDER-030708, PTDC/CTM-NAN/4242/2014 projects and On-SURF (co-financed via FEDER (PT2020) POCI-01-0247-FEDER-024521) projects. The authors would like to acknowledge that this project has received funding from the EU Framework Programme for Research and Innovation H2020, scheme COFUND - Co-funding of Regional, National and International Programmes, under Grant Agreement 713640.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment

  • Bosch, Rosa
  • Carabí-Gassol, Pau
  • MACÍAS CHIMBORAZO, VALERIA
  • Español Martin, Gemma
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Attention-deficit/hyperactivity disorder; Autism spectrum disorder; School performance, Trastorn per dèficit d'atenció i hiperactivitat; Trastorn de l'espectre autista; Rendiment escolar, Trastorno por déficit de atención e hiperactividad; Trastorno del espectro autista; Rendimiento escolar, Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are strongly associated with educational attainment (EA), but little is known about their genetic relationship with school performance and whether these links are explained, in part, by the genetic liability of EA. Here, we aim to dissect the polygenic contribution of ADHD and ASD to school performance, early manifestation of psychopathology and other psychiatric disorders and related traits by their relationship with EA. To do so, we tested the association of polygenic scores for EA, ADHD and ASD with school performance, assessed whether the contribution of the genetic liability of ADHD and ASD to school performance is influenced by the genetic liability of EA, and evaluated the role of EA in the genetic overlap between ADHD and ASD with early manifestation of psychopathology and other psychiatric disorders and related traits in a sample of 4,278 school-age children. The genetic liability for ADHD and ASD dissected by their relationship with EA show differences in their association with school performance and early manifestation of psychopathology, partly mediated by ADHD and ASD symptoms. Genetic variation with concordant effects in ASD and EA contributes to better school performance, while the genetic variation with discordant effects in ADHD or ASD and EA is associated with poor school performance and higher rates of emotional and behavioral problems. Our results strongly support the usage of the genetic load for EA to dissect the genetic and phenotypic heterogeneity of ADHD and ASD, which could help to fill the gap of knowledge of mechanisms underlying educational outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404, PI23/00026 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Network Center for Biomedical Research (CIBER) to J.C.D.; the European Regional Development Fund (ERDF); the ECNP Network ‘ADHD across the Lifespan’; “la Marató de TV3” (202228-30 and 202228-31), “Fundació ‘la Caixa’, Diputació de Barcelona, Pla Estratègic de Recerca i Innovació en Salut” (PERISSLT006/17/285); “Fundació Privada d’Investigació Sant Pau” (FISP); and Ministry of Health of Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The negative impact of neurodevelopmental disorders and multiple co-occurring conditions on academic performance of school-age children and adolescents

  • Autet, Aurea
  • Pagespetit, Èlia
  • Andreu, Maria
  • Pagerols, Mireia
  • Prat, Raquel
  • Español Martin, Gemma
Academic performance; Co-occurring conditions; Neurodevelopmental disorders, Rendiment acadèmic; Condicions concurrents; Trastorns del neurodesenvolupament, Rendimiento académico; Condiciones concurrentes; Trastornos del neurodesarrollo, Students with neurodevelopmental disorders (ND) are at risk for academic impairment. However, the pervasive co-occurrence among these conditions has rarely been considered when evaluating this association. This study examined whether intellectual disabilities (ID), communication disorders, autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), specific learning disorder (SLD), and motor disorders were related to academic outcomes. Parents and teachers completed standardized screening instruments for mental health problems and learning difficulties. Children who screened positive were interviewed for diagnostic confirmation according to the Diagnostic and Statistical Manual of Mental Disorders, while students who screened negative served as controls. Academic performance across multiple subjects was obtained from school records. The final sample comprised 9018 participants aged 5-17. Mixed-effects ordinal logistic regression models determined the independent and combined effects of ND on academic performance, adjusting for background and coexisting conditions. When examined separately, each diagnostic category was significantly associated with lower marks in all educational outcomes, even after adjusting for sociodemographic and school-related factors. However, when the influence of neurodevelopmental co-occurrence was controlled for, ID emerged as the strongest predictor of poor academic performance, followed by ADHD, SLD, and communication disorders. ASD and motor disorders were only associated with lower marks in arts and physical education. Furthermore, youth with coexisting conditions were at higher risk for academic impairment across all subjects. These findings highlight the need for early diagnosis and targeted interventions to address the specific educational needs of students with ND. Likewise, co-occurring diagnoses should be actively sought to avoid disadvantaging children with multiple disorders., This work was funded by Fundació “la Caixa” (LCR/PR/PR20/51150021), Diputació de Barcelona (PR(AG)72-2012 (2016/011627)), Pla Estratègic de Recerca i Innovació en Salut (SLT006/17/00285), Fundació La Marató de TV3 (202228-30-31), Fondo de Investigaciones Sanitarias (PI23/00026, PI23/00040), Agència de Gestió d’Ajuts Universitaris i de Recerca (DI-2024-00034), Fundació d’Investigació Salut i Progrés (FISP), and the Department of Health (Generalitat de Catalunya).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

  • Coignard, Juliette
  • Beesley, Jonathan
  • O'Mara, Tracy A.
  • Diez Gibert, Orland
  • Lopez-Fernandez, Adrià
  • Dennis, Joe
  • Tyrer, Jonathan
  • Lush, Michael
Càncer de mama; Genètica del càncer; Factors de risc, Cáncer de mama; Genética del cáncer; Factores de riesgo, Breast cancer; Cancer genetics; Risk factors, Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10−8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Arribas, Lorena
  • Demontis, Ditte
  • Cabana-Dominguez, Judit
  • Llonga, Natalia
  • Alemany, Silvia
  • Vilar-Ribo, Laura
  • Fadeuilhe, Christian
  • Corrales, Montserrat
  • Richarte, Vanesa
  • Soler Artigas, María
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Transcriptomic risk scores; Attention deficit and hyperactivity disorder, Puntuaciones de riesgo transcriptómico; Trastorno por déficit de atención e hiperactividad, Puntuació de risc transcriptòmic; Trastorn per dèficit d'atenció i hiperactivitat, Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III and co-funded by the European Union Found: Fondo Social Europeo Plus (FSE+) (P19/01224, PI20/00041, PI22/00464 and FI18/00285 to LVR, CP22/00128 to MSA and CP22/00026 to SA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD), the Network Center for Biomedical Research (CIBER) to JCD, the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’ and the “la Marató de TV3” (202228-30 and 202228-31). ADB was supported by grants from the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003) and NIH/NIMH (1R01MH124851-01). DD was supported by the Novo Nordisk Foundation (NNF20OC0065561) and the Lundbeck Foundation (R344-2020-1060).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores

  • GRAU-LÓPEZ, LARA
  • Daigre, Constanza
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Heterogeneity; Substance use disorder; Genome, Heterogeneidad; Trastorno por consumo de sustancias; Genoma, Heterogeneïtat; Trastorn per consum de substàncies; Genoma, Substance use disorder (SUD) is a global health problem with a significant impact on individuals and society. The presentation of SUD is diverse, involving various substances, ages at onset, comorbid conditions, and disease trajectories. Current treatments for SUD struggle to address this heterogeneity, resulting in high relapse rates. SUD often co-occurs with other psychiatric and mental health-related conditions that contribute to the heterogeneity of the disorder and predispose to adverse disease trajectories. Family and genetic studies highlight the role of genetic and environmental factors in the course of SUD, and point to a shared genetic liability between SUDs and comorbid psychopathology. In this study, we aimed to disentangle SUD heterogeneity using a deeply phenotyped SUD cohort and polygenic scores (PGSs) for psychiatric disorders and related traits. We explored associations between PGSs and various SUD-related phenotypes, as well as PGS-environment interactions using information on lifetime emotional, physical, and/or sexual abuse. Our results identify clusters of individuals who exhibit differences in their phenotypic profile and reveal different patterns of associations between SUD-related phenotypes and the genetic liability for mental health-related traits, which may help explain part of the heterogeneity observed in SUD. In our SUD sample, we found associations linking the genetic liability for attention-deficit hyperactivity disorder (ADHD) with lower educational attainment, the genetic liability for post-traumatic stress disorder (PTSD) with higher rates of unemployment, the genetic liability for educational attainment with lower rates of criminal records and unemployment, and the genetic liability for well-being with lower rates of outpatient treatments and fewer problems related to family and social relationships. We also found evidence of PGS-environment interactions showing that genetic liability for suicide attempts worsened the psychiatric status in SUD individuals with a history of emotional physical and/or sexual abuse. Collectively, these data contribute to a better understanding of the role of genetic liability for mental health-related conditions and adverse life experiences in SUD heterogeneity., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840 and 2021-SGR-01093), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to M.S.A, RYC2021-031324-I to J.C.D and PID2021-1277760B-I100 to B.C. and N.F-C.), the Ministry of Health, Social Services and Equality (PNSD-2020I042 to N.F-C.), the Network Center for Biomedical Research (CIBER) to J.C.D., the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’, “Fundació La Marató de TV3” (202228-30, 202228-31 and 202218-31) and ICREA Academia 2021.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comprehensive establishment and characterization of orthoxenograft mouse models of malignant peripheral nerve sheath tumors for personalized medicine

  • Castellsagué, Joan|||0000-0002-2579-3137
  • Gel, Bernat|||0000-0001-8878-349X
  • Fernández-Rodríguez, Juana
  • Llatjós, Roger
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Benavente, Yolanda|||0000-0003-1422-4614
  • Pérez-Sidelnikova, Diana
  • Garcia del Muro, Xavier|||0000-0001-5571-2847
  • Viñals, Joan Maria
  • Vidal, August|||0000-0001-5727-2099
  • Valdés-Mas, Rafael
  • Terribas, Ernest
  • López-Doriga, Adriana
  • Pujana, Miguel Angel|||0000-0003-3222-4044
  • Capella, Gabriel|||0000-0002-4669-7320
  • Puente, Xose S.|||0000-0001-9525-1483
  • Serra, Eduard|||0000-0003-2895-9857
  • Villanueva Garatachea, Alberto
  • Lázaro García, Conxi|||0000-0002-7198-5906
Malignant peripheral nerve sheath tumors (MPNSTs) are soft-tissue sarcomas that can arise either sporadically or in association with neurofibromatosis type 1 (NF1). These aggressive malignancies confer poor survival, with no effective therapy available. We present the generation and characterization of five distinct MPNST orthoxenograft models for preclinical testing and personalized medicine. Four of the models are patient-derived tumor xenografts (PDTX), two independent MPNSTs from the same NF1 patient and two from different sporadic patients. The fifth model is an orthoxenograft derived from an NF1-related MPNST cell line. All MPNST orthoxenografts were generated by tumor implantation, or cell line injection, next to the sciatic nerve of nude mice, and were perpetuated by 7-10 mouse-to-mouse passages. The models reliably recapitulate the histopathological properties of their parental primary tumors. They also mimic distal dissemination properties in mice. Human stroma was rapidly lost after MPNST engraftment and replaced by murine stroma, which facilitated genomic tumor characterization. Compatible with an origin in a catastrophic event and subsequent genome stabilization, MPNST contained highly altered genomes that remained remarkably stable in orthoxenograft establishment and along passages. Mutational frequency and type of somatic point mutations were highly variable among the different MPNSTs modeled, but very consistent when comparing primary tumors with matched orthoxenografts generated. Unsupervised cluster analysis and principal component analysis (PCA) using an MPNST expression signature of ~1,000 genes grouped together all primary tumor-orthoxenograft pairs. Our work points to differences in the engraftment process of primary tumors compared with the engraftment of established cell lines. Following standardization and extensive characterization and validation, the orthoxenograft models were used for initial preclinical drug testing. Sorafenib (a BRAF inhibitor), in combination with doxorubicin or rapamycin, was found to be the most effective treatment for reducing MPNST growth. The development of genomically well-characterized preclinical models for MPNST allowed the evaluation of novel therapeutic strategies for personalized medicine.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Accelerated geroncogenesis in hereditary breast-ovarian cancer syndrome

  • Menéndez, Javier A.|||0000-0001-8733-4561
  • Folguera Blasco, Núria|||0000-0003-1584-5885
  • Cuyàs, Elisabet|||0000-0001-5353-440X
  • Fernández-Arroyo, Salvador
  • Joven, Jorge|||0000-0003-2749-4541
  • Alarcón Cor, Tomás|||0000-0002-8566-3676
The geroncogenesis hypothesis postulates that the decline in metabolic cellular health that occurs naturally with aging drives a "field effect" predisposing normal tissues for cancer development. We propose that mutations in the cancer susceptibility genes BRCA1/2 might trigger "accelerated geroncogenesis" in breast and ovarian epithelia. By speeding up the rate at which the metabolic threshold becomes "permissive" with survival and expansion of genomically unstable pre-tumoral epithelial cells, BRCA haploinsufficiency-driven metabolic reprogramming would operate as a bona fide oncogenic event enabling malignant transformation and tumor formation in BRCA carriers. The metabolic facet of BRCA1 one-hit might involve tissue-specific alterations in acetyl-CoA, α-ketoglutarate, NAD +, FAD, or S-adenosylmethionine, critical factors for de/methylation or de/acetylation dynamics in the nuclear epigenome. This in turn might induce faulty epigenetic reprogramming at the "install phase" that directs cell-specific differentiation of breast/ovarian epithelial cells, which can ultimately determine the penetrance of BRCA defects during developmental windows of susceptibility. This model offers a framework to study whether metabolic drugs that prevent or revert metabolic reprogramming induced by BRCA haploinsufficiency might displace the "geroncogenic risk" of BRCA carriers to the age typical for those without the mutation. The identification of the key nodes that directly communicate changes in cellular metabolism to the chromatin in BRCA haploinsufficient cells may allow the epigenetic targeting of genomic instability using exclusively metabolic means. The validation of accelerated geroncogenesis as an inherited "one-hit" metabolic "field effect" might offer new strategies to therapeutically revisit the apparently irreversible genetic-hereditary fate of women with hereditary breast-ovarian cancer syndrome.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis, evidence for metformin-based "starvation" strategies in BRCA1 carriers

  • Cuyàs, Elisabet|||0000-0001-5353-440X
  • Fernández-Arroyo, Salvador
  • Alarcón Cor, Tomás|||0000-0002-8566-3676
  • Joven, Jorge|||0000-0003-2749-4541
  • Menéndez, Javier A.|||0000-0001-8733-4561
We hypothesized that women inheriting one germline mutation of the BRCA1 gene ("one-hit") undergo cell-type-specific metabolic reprogramming that supports the high biosynthetic requirements of breast epithelial cells to progress to a fully malignant phenotype. Targeted metabolomic analysis was performed in isogenic pairs of nontumorigenic human breast epithelial cells in which the knock-in of 185delAG mutation in a single BRCA1 allele leads to genomic instability. Mutant BRCA1 one-hit epithelial cells displayed constitutively enhanced activation of biosynthetic nodes within mitochondria. This metabolic rewiring involved the increased incorporation of glutamine- and glucose-dependent carbon into tricarboxylic acid (TCA) cycle metabolite pools to ultimately generate elevated levels of acetyl-CoA and malonyl-CoA, the major building blocks for lipid biosynthesis. The significant increase of branched-chain amino acids (BCAAs) including the anabolic trigger leucine, which can not only promote protein translation via mTOR but also feed into the TCA cycle via succinyl-CoA, further underscored the anabolic reprogramming of BRCA1 haploinsufficient cells. The anti-diabetic biguanide metformin "reversed" the metabolomic signature and anabolic phenotype of BRCA1 one-hit cells by shutting down mitochondria-driven generation of precursors for lipogenic pathways and reducing the BCAA pool for protein synthesis and TCA fueling. Metformin-induced restriction of mitochondrial biosynthetic capacity was sufficient to impair the tumor-initiating capacity of BRCA1 one-hit cells in mammosphere assays. Metabolic rewiring of the breast epithelium towards increased anabolism might constitute an unanticipated and inherited form of metabolic reprogramming linked to increased risk of oncogenesis in women bearing pathogenic germline BRCA1 mutations. The ability of metformin to constrain the production of mitochondrial-dependent biosynthetic intermediates might open a new avenue for "starvation" chemopreventive strategies in BRCA1 carriers.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1

  • Hernández Viedma, Gonzalo|||0000-0002-3048-9607
  • Ramírez de Haro, Ma. José|||0000-0003-1417-7731
  • Minguillón Pedreño, Jordi|||0000-0003-2124-8294
  • Quiles, Francisco
  • Ruiz de Garibay, G.
  • Aza-Carmona, Miriam|||0000-0003-4448-9541
  • Bogliolo, Massimo|||0000-0001-8240-7784
  • Pujol Calvet, Maria Roser|||0000-0003-1840-5455
  • Prados-Carvajal, Rosario
  • Fernández-Rodríguez, Juana
  • García, Nadia
  • López, Adrià
  • Gutiérrez-Enríquez, Sara|||0000-0002-1711-6101
  • Diez, Orland|||0000-0001-7339-0570
  • Benitez, Javier|||0000-0002-0923-7202
  • Salinas, Monica
  • Teule, Alex|||0000-0003-0028-7200
  • Brunet, Joan|||0000-0003-1945-3512
  • Radice, Paolo|||0000-0001-6298-4111
  • Peterlongo, Paolo|||0000-0001-6951-6855
  • Schindler, Detlev
  • Huertas, Pablo
  • Puente, Xose P.
  • Lázaro, Coxi
  • Pujana, Miguel Angel|||0000-0003-3222-4044
  • Surralles, Jordi|||0000-0002-4041-7519
BRCA1 is a tumor suppressor that regulates DNA repair by homologous recombination. Germline mutations in BRCA1 are associated with increased risk of breast and ovarian cancer and BRCA1 deficient tumors are exquisitely sensitive to poly (ADP-ribose) polymerase (PARP) inhibitors. Therefore, uncovering additional components of this DNA repair pathway is of extreme importance for further understanding cancer development and therapeutic vulnerabilities. Here, we identify EDC4, a known component of processing-bodies and regulator of mRNA decapping, as a member of the BRCA1-BRIP1-TOPBP1 complex. EDC4 plays a key role in homologous recombination by stimulating end resection at double-strand breaks. EDC4 deficiency leads to genome instability and hypersensitivity to DNA interstrand cross-linking drugs and PARP inhibitors. Lack-of-function mutations in EDC4 were detected in BRCA1/2-mutation-negative breast cancer cases, suggesting a role in breast cancer susceptibility. Collectively, this study recognizes EDC4 with a dual role in decapping and DNA repair whose inactivation phenocopies BRCA1 deficiency.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer

  • Feliubadaló, Lidia|||0000-0002-1736-0112
  • Tonda, Raúl
  • Gausachs, Mireia
  • Trotta, Jean-Rémi
  • Castellanos, Elisabeth|||0000-0002-8133-5325
  • López-Doriga, Adriana
  • Teule, Alex|||0000-0003-0028-7200
  • Tornero, Eva
  • Del Valle, Jesús|||0000-0003-3607-7045
  • Gel, Bernat|||0000-0001-8878-349X
  • Gut, Marta|||0000-0002-4063-7159
  • Pineda, Marta|||0000-0002-5403-5845
  • González, Sara
  • Menéndez, Mireia
  • Navarro, Matilde
  • Capella, Gabriel|||0000-0002-4669-7320
  • Gut, Ivo|||0000-0001-7219-632X
  • Serra, Eduard|||0000-0003-2895-9857
  • Brunet, Joan|||0000-0003-1945-3512
  • Beltran i Agulló, Sergi|||0000-0002-2810-3445
  • Lázaro García, Conxi|||0000-0002-7198-5906
Next generation sequencing panels have been developed for hereditary cancer, although there is some debate about their cost-effectiveness compared to exome sequencing. The performance of two panels is compared to exome sequencing. Twenty-four patients were selected: ten with identified mutations (control set) and fourteen suspicious of hereditary cancer but with no mutation (discovery set). TruSight Cancer (94 genes) and a custom panel (122 genes) were assessed alongside exome sequencing. Eightythree genes were targeted by the two panels and exome sequencing. More than 99% of bases had a read depth of over 30x in the panels, whereas exome sequencing covered 94%. Variant calling with standard settings identified the 10 mutations in the control set, with the exception of MSH6 c.255dupC using TruSight Cancer. In the discovery set, 240 unique non-silent coding and canonic splice-site variants were identified in the panel genes, 7 of them putatively pathogenic (in ATM, BARD1, CHEK2, ERCC3, FANCL, FANCM, MSH2). The three approaches identified a similar number of variants in the shared genes. Exomes were more expensive than panels but provided additional data. In terms of cost and depth, panels are a suitable option for genetic diagnostics, although exomes also identify variants in non-targeted genes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT), initial results from an international prospective study

  • Bancroft, Elizabeth|||0000-0002-5482-5660
  • Page, Elizabeth C.
  • Brook, Mark N.|||0000-0002-8969-2378
  • Thomas, Sarah
  • Taylor, Natalie
  • Pope, Jennifer
  • McHugh, Jana
  • Jones, Ann-Britt
  • Karlsson, Questa
  • Merson, Susan
  • Ong, Kai Ren
  • Hoffman, Jonathan
  • Huber, Camilla
  • Maehle, Lovise
  • Grindedal, Eli Marie
  • Stormorken, Astrid
  • Evans, Gareth|||0000-0002-8482-5784
  • Rothwell, Jeanette
  • Lalloo, Fiona
  • Brady, Angela F.
  • Bartlett, Marion
  • Snape, Katie
  • Hanson, Helen
  • James, Paul|||0000-0002-4361-4657
  • McKinley, Joanne
  • Mascarenhas, Lyon
  • Syngal, Sapna
  • Ukaegbu, Chinedu
  • Side, Lucy
  • Thomas, Tessy
  • Barwell, Julian
  • Teixeira, Manuel R.|||0000-0002-4896-5982
  • Izatt, Louise|||0000-0003-1258-4843
  • Suri, Mohnish|||0000-0001-9037-701X
  • Macrae, Finlay A.
  • Poplawski, Nicola
  • Chen-Shtoyerman, Rakefet|||0000-0002-5055-5907
  • Ahmed, Munaza
  • Musgrave, Hannah
  • Nicolai, Nicola|||0000-0002-5718-2699
  • Greenhalgh, Lynn
  • Brewer, Carole
  • Pachter, Nicholas
  • Spigelman, Allan D.
  • Azzabi, Ashraf
  • Helfand, Brian T.
  • Halliday, Dorothy
  • Buys, Saundra|||0000-0003-4120-5697
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Donaldson, Alan|||0000-0001-9193-4172
  • Cooney, Kathleen A.
  • Harris, Marion
  • McGrath, John
  • Davidson, Rosemarie
  • Taylor, Amy
  • Cooke, Peter
  • Myhill, Kathryn
  • Hogben, Matthew
  • Aaronson, Neil K.
  • Ardern-Jones, Audrey
  • Bangma, Chris H.
  • Castro, Elena|||0000-0002-3691-6454
  • Dearnaley, David|||0000-0002-3954-2806
  • Dias, Alexander
  • Dudderidge, Tim|||0000-0001-6373-3613
  • Eccles, Diana M.|||0000-0002-9935-3169
  • Green, Kate
  • Eyfjord, Jorunn
  • Falconer, Alison
  • Foster, Christopher S.
  • Gronberg, Henrik
  • Hamdy, Freddie C.|||0000-0003-2627-2154
  • Johannsson, Oskar
  • Khoo, Vincent
  • Lilja, Hans|||0000-0001-5871-7846
  • Lindeman, Geoffrey J.|||0000-0001-9386-2416
  • Lubinski, Jan|||0000-0003-2931-3003
  • Axcrona, Karol|||0000-0002-5011-0107
  • Mikropoulos, Christos|||0000-0001-8070-2851
  • Mitra, Anita V.
  • Moynihan, Clare
  • Ni Raghallaigh, Holly
  • Rennert, Gad|||0000-0002-8512-068X
  • Collier, Rebecca
  • Offman, Judith|||0000-0001-5604-1635
  • Kote-Jarai, Zsofia|||0000-0002-6329-5155
  • Eeles, Rosalind|||0000-0002-3698-6241
Lynch syndrome is a rare familial cancer syndrome caused by pathogenic variants in the mismatch repair genes MLH1, MSH2, MSH6, or PMS2, that cause predisposition to various cancers, predominantly colorectal and endometrial cancer. Data are emerging that pathogenic variants in mismatch repair genes increase the risk of early-onset aggressive prostate cancer. The IMPACT study is prospectively assessing prostate-specific antigen (PSA) screening in men with germline mismatch repair pathogenic variants. Here, we report the usefulness of PSA screening, prostate cancer incidence, and tumour characteristics after the first screening round in men with and without these germline pathogenic variants. The IMPACT study is an international, prospective study. Men aged 40-69 years without a previous prostate cancer diagnosis and with a known germline pathogenic variant in the MLH1, MSH2, or MSH6 gene, and age-matched male controls who tested negative for a familial pathogenic variant in these genes were recruited from 34 genetic and urology clinics in eight countries, and underwent a baseline PSA screening. Men who had a PSA level higher than 3·0 ng/mL were offered a transrectal, ultrasound-guided, prostate biopsy and a histopathological analysis was done. All participants are undergoing a minimum of 5 years' annual screening. The primary endpoint was to determine the incidence, stage, and pathology of screening-detected prostate cancer in carriers of pathogenic variants compared with non-carrier controls. We used Fisher's exact test to compare the number of cases, cancer incidence, and positive predictive values of the PSA cutoff and biopsy between carriers and non-carriers and the differences between disease types (ie, cancer vs no cancer, clinically significant cancer vs no cancer). We assessed screening outcomes and tumour characteristics by pathogenic variant status. Here we present results from the first round of PSA screening in the IMPACT study. This study is registered with , , and is now closed to accrual. Between Sept 28, 2012, and March 1, 2020, 828 men were recruited (644 carriers of mismatch repair pathogenic variants [204 carriers of MLH1, 305 carriers of MSH2, and 135 carriers of MSH6 ] and 184 non-carrier controls [65 non-carriers of MLH1, 76 non-carriers of MSH2, and 43 non-carriers of MSH6 ]), and in order to boost the sample size for the non-carrier control groups, we randomly selected 134 non-carriers from the BRCA1 and BRCA2 cohort of the IMPACT study, who were included in all three non-carrier cohorts. Men were predominantly of European ancestry (899 [93%] of 953 with available data), with a mean age of 52·8 years (SD 8·3). Within the first screening round, 56 (6%) men had a PSA concentration of more than 3·0 ng/mL and 35 (4%) biopsies were done. The overall incidence of prostate cancer was 1·9% (18 of 962; 95% CI 1·1-2·9). The incidence among MSH2 carriers was 4·3% (13 of 305; 95% CI 2·3-7·2), MSH2 non-carrier controls was 0·5% (one of 210; 0·0-2·6), MSH6 carriers was 3·0% (four of 135; 0·8-7·4), and none were detected among the MLH1 carriers, MLH1 non-carrier controls, and MSH6 non-carrier controls. Prostate cancer incidence, using a PSA threshold of higher than 3·0 ng/mL, was higher in MSH2 carriers than in MSH2 non-carrier controls (4·3% vs 0·5%; p=0·011) and MSH6 carriers than MSH6 non-carrier controls (3·0% vs 0%; p=0·034). The overall positive predictive value of biopsy using a PSA threshold of 3·0 ng/mL was 51·4% (95% CI 34·0-68·6), and the overall positive predictive value of a PSA threshold of 3·0 ng/mL was 32·1% (20·3-46·0). After the first screening round, carriers of MSH2 and MSH6 pathogenic variants had a higher incidence of prostate cancer compared with age-matched non-carrier controls. These findings support the use of targeted PSA screening in these men to identify those with clinically significant prostate cancer. Further annual screening rounds will need to confirm these findings.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

  • Zeng, Chenjie
  • Guo, Xingyi
  • Long, Jirong
  • Kuchenbaecker, Karoline B.
  • Droit, Arnaud
  • Michailidou, Kyriaki
  • Ghoussaini, Maya
  • Kar, Siddhartha
  • Freeman, Adam
  • Hopper, John L.
  • Milne, Roger L.|||0000-0001-5764-7268
  • Bolla, Manjeet K.|||0000-0002-4351-9326
  • Wang, Qin
  • Dennis, Joe|||0000-0003-4591-1214
  • Agata, Simona
  • Ahmed, Shahana
  • Aittomäki, Kristiina
  • Andrulis, Irene L.|||0000-0002-4226-6435
  • Anton-Culver, Hoda
  • Antonenkova, Natalia N.
  • Arason, Adalgeir|||0000-0003-0480-886X
  • Arndt, Volker|||0000-0001-9320-8684
  • Arun, Banu K.
  • Arver, Brita
  • Bacot, Francois
  • Barrowdale, Daniel|||0000-0003-1661-3939
  • Baynes, Caroline
  • Beeghly-Fadiel, Alicia|||0000-0001-9913-732X
  • Benitez, Javier|||0000-0002-0923-7202
  • Bermisheva, Marina
  • Blomqvist, Carl
  • Blot, William
  • Bogdanova, Natalia V.
  • Bojesen, Stig E.
  • Bonanni, Bernardo|||0000-0003-3589-2128
  • Borresen-Dale, Anne-Lise
  • Brand, Judith S.
  • Brauch, Hiltrud|||0000-0001-7531-2736
  • Brennan, Paul
  • Brenner, Hermann
  • Broeks, Annegien
  • Brüning, Thomas
  • Burwinkel, Barbara
  • Buys, Saundra|||0000-0003-4120-5697
  • Cai, Qiuyin
  • Caldes, Trinidad
  • Campbell, Ian|||0000-0002-7773-4155
  • Carpenter, Jane
  • Chang-Claude, Jenny
  • Choi, Ji-Yeob
  • Claes, Kathleen|||0000-0003-0841-7372
  • Clarke, Christine L.
  • Cox, Angela
  • Cross, Simon S.
  • Czene, Kamila
  • Daly, Mary B.
  • Hoya, Miguel de la|||0000-0002-8113-1410
  • De Leeneer, Kim
  • Devilee, Peter|||0000-0002-8023-2009
  • Diez, Orland|||0000-0001-7339-0570
  • Domchek, Susan M.|||0000-0002-5914-7272
  • Doody, Michele
  • Dorfling, Cecilia M.
  • Dörk, Thilo|||0000-0002-9458-0282
  • dos-Santos-Silva, Isabel
  • Dumont, Martine
  • Dwek, Miriam
  • Dworniczak, Bernd
  • Egan, Kathleen
  • Eilber, Ursula
  • Einbeigi, Zakaria
  • Ejlertsen, Bent
  • Ellis, Steve
  • Frost, Debra
  • Lalloo, Fiona
  • Fasching, Peter A.
  • Figueroa, Jonine
  • Flyger, Henrik
  • Friedlander, Michael|||0000-0003-3090-795X
  • Friedman, Eitan|||0000-0002-6745-1733
  • Gambino, Gaetana
  • Gao, Yu-Tang
  • Garber, Judy
  • García-Closas, Montserrat
  • Gehrig, Andrea
  • Damiola, Francesca
  • Lesueur, Fabienne|||0000-0001-7404-4549
  • Mazoyer, Sylvie
  • Stoppa-Lyonnet, Dominique
  • Giles, Graham G.
  • Godwin, Andrew K.|||0000-0002-3987-9580
  • Goldgar, David E.
  • González-Neira, Anna
  • Greene, Mark H.|||0000-0003-1852-9239
  • Guénel, Pascal
  • Haeberle, Lothar
  • Haiman, Christopher A.
  • Hallberg, Emily
  • Hamann, Ute|||0000-0001-6705-7624
  • Hansen, Thomas V. O.
  • Hart, Steven
  • Hartikainen, Jaana M.
  • Hartman, Mikael
  • Hassan, Norhashimah
  • Healey, Sue
  • Hogervorst, Frans B. L.
  • Verhoef, Senno
  • Hendricks, Carolyn B.
  • Hillemanns, Peter
  • Hollestelle, Antoinette
  • Hulick, Peter J.
  • Hunter, David J.
  • Imyanitov, Evgeny N.
  • Isaacs, Claudine|||0000-0002-9646-1260
  • Ito, Hidemi
  • Jakubowska, Anna|||0000-0002-5650-0501
  • Janavicius, Ramunas
  • Jaworska-Bieniek, Katarzyna
  • Jensen, Uffe Birk
  • John, Esther M.
  • Joly Beauparlant, Charles
  • Jones, Michael
  • Kabisch, Maria
  • Kang, Daehee
  • Karlan, Beth Y.|||0000-0002-9451-2933
  • Kauppila, Saila
  • Kerin, Michael J.
  • Khan, Sofia
  • Khusnutdinova, Elza
  • Knight, Julia A.
  • Konstantopoulou, Irene|||0000-0002-0470-0309
  • Kraft, Peter
  • Kwong, Ava
  • Laitman, Yael
  • Lambrechts, Diether
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Le Marchand, Loic
  • Lee, Chuen Neng
  • Lee, Min Hyuk
  • Lester, Jenny
  • Li, Jingmei
  • Liljegren, Annelie
  • Lindblom, Annika
  • Lophatananon, Artitaya
  • Lubinski, Jan|||0000-0003-2931-3003
  • Mai, Phuong L.
  • Mannermaa, Arto
  • Manoukian, Siranoush
  • Margolin, Sara
  • Marme, Frederik
  • Matsuo, Keitaro
  • McGuffog, Lesley|||0000-0003-1237-0546
  • Meindl, Alfons
  • Menegaux, Florence
  • Montagna, Marco
  • Muir, Kenneth
  • Mulligan, Anna Marie
  • Nathanson, Katherine L.|||0000-0002-6740-0901
  • Neuhausen, Susan L.|||0000-0001-5053-0390
  • Nevanlinna, Heli|||0000-0002-0916-2976
  • Newcomb, Polly A.
  • Nord, Silje
  • Nussbaum, Robert L.|||0000-0003-3445-8880
  • Offit, Kenneth
  • Olah, Edith
  • Olopade, Olufunmilayo I.|||0000-0002-9936-1599
  • Olswold, Curtis
  • Osorio, Ana|||0000-0001-8124-3984
  • Papi, Laura
  • Park-Simon, Tjoung-Won
  • Paulsson-Karlsson, Ylva
  • Peeters, Stephanie
  • Peissel, Bernard|||0000-0001-9233-3571
  • Peterlongo, Paolo|||0000-0001-6951-6855
  • Peto, Julian|||0000-0002-1685-8912
  • Pfeiler, Georg
  • Phelan, Catherine M.
  • Presneau, Nadege
  • Radice, Paolo|||0000-0001-6298-4111
  • Rahman, Nazneen
  • Ramus, Susan J.|||0000-0003-0005-7798
  • Rashid, Muhammad Usman
  • Rennert, Gad|||0000-0002-8512-068X
  • Rhiem, Kerstin
  • Rudolph, Anja
  • Salani, Ritu
  • Sangrajrang, Suleeporn
  • Sawyer, Elinor J.
  • Schmidt, Marjanka K.|||0000-0002-2228-429X
  • Schmutzler, Rita K.
  • Schoemaker, Minouk J.
  • Schürmann, Peter
  • Seynaeve, Caroline
  • Shen, Chen-Yang
  • Shrubsole, Martha J.
  • Shu, Xiao-Ou
  • Sigurdson, Alice
  • Singer, Christian F.
  • Slager, Susan|||0000-0002-5173-4712
  • Soucy, Penny
  • Southey, Melissa C.|||0000-0002-6313-9005
  • Steinemann, Doris|||0000-0001-8797-0816
  • Swerdlow, Anthony
  • Szabo, Csilla I.
  • Tchatchou, Sandrine
  • Teixeira, Manuel R.|||0000-0002-4896-5982
  • Teo, Soo|||0000-0002-0444-590X
  • Terry, Mary Beth
  • Tessier, Daniel C.
  • Teule, Alex|||0000-0003-0028-7200
  • Thomassen, Mads
  • Tihomirova, Laima
  • Tischkowitz, Marc
  • Toland, Amanda Ewart|||0000-0002-0271-1792
  • Tung, Nadine
  • Turnbull, Clare
  • van den Ouweland, Ans M. W.
  • van Rensburg, Elizabeth J.|||0000-0003-2077-230X
  • ven den Berg, David
  • Vijai, Joseph
  • Wang-Gohrke, Shan
  • Weitzel, Jeffrey N.
  • Whittemore, Alice S.
  • Winqvist, Robert
  • Wong, Tien Y.
  • Wu, Anna H.
  • Yannoukakos, Drakoulis
  • Yu, Jyh-Cherng
  • Pharoah, Paul D.P.|||0000-0001-8494-732X
  • Hall, Per
  • Chenevix-Trench, Georgia
  • Dunning, Alison M.
  • Simard, Jacques|||0000-0001-6906-3390
  • Couch, Fergus J.
  • Antoniou, Antonis C.
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Zheng, Wei|||0000-0003-1226-070X
Multiple recent genome-wide association studies (GWAS) have identified a single nucleotide polymorphism (SNP), rs10771399, at 12p11 that is associated with breast cancer risk. We performed a fine-scale mapping study of a 700 kb region including 441 genotyped and more than 1300 imputed genetic variants in 48,155 cases and 43,612 controls of European descent, 6269 cases and 6624 controls of East Asian descent and 1116 cases and 932 controls of African descent in the Breast Cancer Association Consortium (BCAC; ), and in 15,252 BRCA1 mutation carriers in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Stepwise regression analyses were performed to identify independent association signals. Data from the Encyclopedia of DNA Elements project (ENCODE) and the Cancer Genome Atlas (TCGA) were used for functional annotation. Analysis of data from European descendants found evidence for four independent association signals at 12p11, represented by rs7297051 (odds ratio (OR) = 1.09, 95 % confidence interval (CI) = 1.06-1.12; P = 3 × 10 -9), rs805510 (OR = 1.08, 95 % CI = 1.04-1.12, P = 2 × 10 -5), and rs1871152 (OR = 1.04, 95 % CI = 1.02-1.06; P = 2 × 10 -4) identified in the general populations, and rs113824616 (P = 7 × 10 -5) identified in the meta-analysis of BCAC ER-negative cases and BRCA1 mutation carriers. SNPs rs7297051, rs805510 and rs113824616 were also associated with breast cancer risk at P < 0.05 in East Asians, but none of the associations were statistically significant in African descendants. Multiple candidate functional variants are located in putative enhancer sequences. Chromatin interaction data suggested that PTHLH was the likely target gene of these enhancers. Of the six variants with the strongest evidence of potential functionality, rs11049453 was statistically significantly associated with the expression of PTHLH and its nearby gene CCDC91 at P < 0.05. This study identified four independent association signals at 12p11 and revealed potentially functional variants, providing additional insights into the underlying biological mechanism(s) for the association observed between variants at 12p11 and breast cancer risk. The online version of this article (doi:10.1186/s13058-016-0718-0) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Kuchenbaecker, Karoline|||0000-0001-9726-603X
  • Cuadras, Daniel|||0000-0001-8780-1764
  • Wang, Xianshu
  • Barrowdale, Daniel|||0000-0003-1661-3939
  • Ruiz de Garibay, Gorka|||0000-0001-9936-8419
  • Librado, Pablo
  • Sánchez-Gracia, Alejandro|||0000-0003-4543-4577
  • Rozas, Julio|||0000-0002-6839-9148
  • Bonifaci, Núria|||0000-0002-8193-6825
  • McGuffog, Lesley|||0000-0003-1237-0546
  • Pankratz, Vernon S.
  • Islam, Abul
  • Mateo, Francesca|||0000-0002-2342-7010
  • Berenguer-Llergo, Antoni|||0000-0002-3742-8161
  • Petit Montserrat, Anna|||0000-0002-9284-095X
  • Català, Isabel
  • Brunet, Joan|||0000-0003-1945-3512
  • Feliubadaló, Lidia|||0000-0002-1736-0112
  • Tornero, Eva
  • Benitez, Javier|||0000-0002-0923-7202
  • Osorio, Ana|||0000-0001-8124-3984
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Aittomäki, Kristiina
  • Arun, Banu K.
  • Toland, Amanda Ewart|||0000-0002-0271-1792
  • Karlan, Beth Y.|||0000-0002-9451-2933
  • Walsh, Christine
  • Lester, Jenny
  • Greene, Mark H.|||0000-0003-1852-9239
  • Mai, Phuong L.
  • Nussbaum, Robert L.|||0000-0003-3445-8880
  • Andrulis, Irene L.|||0000-0002-4226-6435
  • Domchek, Susan M.|||0000-0002-5914-7272
  • Nathanson, Katherine L.|||0000-0002-6740-0901
  • Rebbeck, Timothy R.
  • Barkardottir, Rosa B.
  • Jakubowska, Anna|||0000-0002-5650-0501
  • Lubinski, Jan|||0000-0003-2931-3003
  • Durda, Katarzyna
  • Jaworska-Bieniek, Katarzyna
  • Claes, Kathleen|||0000-0003-0841-7372
  • Van Maerken, Tom
  • Diez, Orland|||0000-0001-7339-0570
  • Hansen, Thomas V.
  • Jønson, Lars
  • Gerdes, Anne-Marie
  • Ejlertsen, Bent
  • Hoya, Miguel de la|||0000-0002-8113-1410
  • Caldes, Trinidad
  • Dunning, Alison M.
  • Oliver, Clare
  • Fineberg, Elena
  • Cook, Margaret
  • Peock, Susan
  • McCann, Emma
  • Murray, Alex
  • Jacobs, Chris
  • Pichert, Gabriella
  • Lalloo, Fiona
  • Chu, Carol
  • Dorkins, Huw
  • Paterson, Joan
  • Ong, Kai-Ren
  • Teixeira, Manuel R.|||0000-0002-4896-5982
  • Hogervorst, Frans B. L.
  • van der Hout, Annemarie H.
  • Seynaeve, Caroline
  • van der Luijt, Rob B.
  • Ligtenberg, Marjolijn J. L.
  • Devilee, Peter|||0000-0002-8023-2009
  • Wijnen, Juul T.
  • Rookus, Matti A.
  • Meijers-Heijboer, Hanne E. J.
  • Blok, Marinus J.|||0000-0002-7935-5933
  • van den Ouweland, Ans M. W.
  • Aalfs, Cora M.
  • Rodriguez, Gustavo C.
  • Phillips, Kelly-Anne|||0000-0002-0475-1771
  • Piedmonte, Marion
  • Nerenstone, Stacy R.
  • Bae-Jump, Victoria L.
  • O'Malley, David M.
  • Ratner, Elena S.
  • Schmutzler, Rita K.
  • Wappenschmidt, Barbara
  • Rhiem, Kerstin
  • Engel, Christoph
  • Meindl, Alfons
  • Ditsch, Nina
  • Arnold, Norbert
  • Plendl, Hansjoerg J.
  • Niederacher, Dieter
  • Sutter, Christian|||0000-0003-4051-5888
  • Wang-Gohrke, Shan
  • Steinemann, Doris|||0000-0001-8797-0816
  • Preisler-Adams, Sabine
  • Kast, Karin|||0000-0001-6531-755X
  • Varon-Mateeva, Raymonda
  • Gehrig, Andrea
  • Bojesen, Anders|||0000-0003-4289-8595
  • Pedersen, Inge Sokilde
  • Sunde, Lone
  • Jensen, Uffe Birk
  • Thomassen, Mads
  • Kruse, Torben A.
  • Foretova, Lenka|||0000-0003-0494-2620
  • Peterlongo, Paolo|||0000-0001-6951-6855
  • Bernard, Loris
  • Peissel, Bernard|||0000-0001-9233-3571
  • Scuvera, Giulietta
  • Manoukian, Siranoush
  • Radice, Paolo|||0000-0001-6298-4111
  • Ottini, Laura
  • Montagna, Marco
  • Agata, Simona
  • Maugard, Christine
  • Simard, Jacques|||0000-0001-6906-3390
  • Soucy, Penny
  • Berger, Andreas|||0000-0001-5865-6609
  • Fink-Retter, Anneliese
  • Singer, Christian F.
  • Rappaport, Christine
  • Geschwantler-Kaulich, Daphne
  • Tea, Muy-Kheng
  • Pfeiler, Georg
  • John, Esther M.
  • Miron, Alex
  • Neuhausen, Susan L.|||0000-0001-5053-0390
  • Terry, Mary Beth
  • Chung, Wendy
  • Daly, Mary B.
  • Goldgar, David E.
  • Janavicius, Ramunas
  • Dorfling, Cecilia M.
  • van Rensburg, Elisabeth J.
  • Fostira, Florentia
  • Konstantopoulou, Irene|||0000-0002-0470-0309
  • Garber, Judy
  • Godwin, Andrew K.|||0000-0002-3987-9580
  • Olah, Edith
  • Narod, Steven A.
  • Rennert, Gad|||0000-0002-8512-068X
  • Paluch, Shani Shimon
  • Laitman, Yael
  • Friedman, Eitan|||0000-0002-6745-1733
  • Liljegren, Annelie
  • Rantala, Johanna
  • Stenmark-Askmalm, Marie
  • Loman, Niklas
  • Imyanitov, Evgeny N.
  • Hamann, Ute|||0000-0001-6705-7624
  • Spurdle, Amanda B.
  • Healey, Sue
  • Weitzel, Jeffrey N.
  • Herzog, Josef
  • Margileth, David
  • Gorrini, Chiara
  • Esteller, M.|||0000-0003-4490-6093
  • Gómez Moruno, Antonio|||0000-0001-5308-981X
  • Sayols, Sergi|||0000-0002-3877-4170
  • Vidal, Enrique
  • Heyn, Holger|||0000-0002-3276-1889
  • Stoppa-Lyonnet, Dominique
  • Léoné, Melanie
  • Barjhoux, Laure
  • Fassy-Colcombet, Marion
  • De Pauw, Antoine|||0000-0003-3898-073X
  • Lasset, Christine
  • Ferrer, Sandra Fert
  • Castera, Laurent
  • Berthet, Pascaline
  • Cornelis, François
  • Bignon, Yves-Jean
  • Damiola, Francesca
  • Mazoyer, Sylvie
  • Sinilnikova, Olga M.
  • Maxwell, Christopher A.
  • Vijai, Joseph
  • Robson, Mark
  • Kauff, Noah
  • Corines, Marina|||0000-0001-8472-4046
  • Villano, Danylko
  • Cunningham, Julie M.
  • Lee, Adam
  • Lindor, Noralane M.
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Offit, Kenneth
  • Chenevix-Trench, Georgia
  • Couch, Fergus J.
  • Antoniou, Antonis C.
  • Pujana, Miguel Angel|||0000-0003-3222-4044
While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Forty-one single nucleotide polymorphisms (SNPs) were genotyped in 15,252 BRCA1 and 8,211 BRCA2 mutation carriers and subsequently analyzed using a retrospective likelihood approach. The association of HMMR rs299290 with breast cancer risk in BRCA1 mutation carriers was confirmed: per-allele hazard ratio (HR) = 1.10, 95% confidence interval (CI) 1.04 - 1.15, p = 1.9 x 10 -4 (false discovery rate (FDR)-adjusted p = 0.043). Variation in CSTF1, located next to AURKA, was also found to be associated with breast cancer risk in BRCA2 mutation carriers: rs2426618 per-allele HR = 1.10, 95% CI 1.03 - 1.16, p = 0.005 (FDR-adjusted p = 0.045). Assessment of pairwise interactions provided suggestions (FDR-adjusted p values.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

An original phylogenetic approach identified mitochondrial haplogrou,p T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

  • Blein, Sophie
  • Bardel, Claire
  • Danjean, Vincent
  • McGuffog, Lesley|||0000-0003-1237-0546
  • Healey, Sue
  • Barrowdale, Daniel|||0000-0003-1661-3939
  • Lee, Andrew
  • Dennis, Joe|||0000-0003-4591-1214
  • Kuchenbaecker, Karoline B.
  • Soucy, Penny
  • Terry, Mary Beth
  • Chung, Wendy
  • Goldgar, David E.
  • Buys, Saundra|||0000-0003-4120-5697
  • Janavicius, Ramunas
  • Tihomirova, Laima
  • Tung, Nadine
  • Dorfling, Cecilia M.
  • van Rensburg, Elizabeth J.|||0000-0003-2077-230X
  • Neuhausen, Susan L.|||0000-0001-5053-0390
  • Ding, Yuan Chun
  • Gerdes, Anne-Marie
  • Ejlertsen, Bent
  • Nielsen, Finn C.
  • Hansen, Thomas V. O.
  • Osorio, Ana|||0000-0001-8124-3984
  • Benitez, Javier|||0000-0002-0923-7202
  • Andrés Conejero, Raquel
  • Segota, Ena
  • Weitzel, Jeffrey N.
  • Thelander, Margo
  • Peterlongo, Paolo|||0000-0001-6951-6855
  • Radice, Paolo|||0000-0001-6298-4111
  • Pensotti, Valeria
  • Dolcetti, Riccardo
  • Bonanni, Bernardo|||0000-0003-3589-2128
  • Peissel, Bernard|||0000-0001-9233-3571
  • Zaffaroni, Daniela|||0000-0002-6995-2216
  • Scuvera, Giulietta
  • Manoukian, Siranoush
  • Varesco, Liliana
  • Capone, Gabriele L.
  • Papi, Laura
  • Ottini, Laura
  • Yannoukakos, Drakoulis
  • Konstantopoulou, Irene|||0000-0002-0470-0309
  • Garber, Judy
  • Hamann, Ute|||0000-0001-6705-7624
  • Donaldson, Alan|||0000-0001-9193-4172
  • Brady, Angela
  • Brewer, Carole
  • Foo, Claire
  • Evans, Gareth|||0000-0002-8482-5784
  • Frost, Debra
  • Eccles, Diana M.|||0000-0002-9935-3169
  • Douglas, Fiona
  • Cook, Jackie
  • Adlard, Julian|||0000-0002-1693-0435
  • Barwell, Julian
  • Walker, Lisa
  • Izatt, Louise|||0000-0003-1258-4843
  • Side, Lucy E.
  • Kennedy, M. John
  • Tischkowitz, Marc
  • Rogers, Mark T.
  • Porteous, Mary E.
  • Morrison, Patrick J.
  • Platte, Radka
  • Eeles, Rosalind|||0000-0002-3698-6241
  • Davidson, Rosemarie
  • Hodgson, Shirley
  • Cole, Trevor
  • Godwin, Andrew K.|||0000-0002-3987-9580
  • Isaacs, Claudine|||0000-0002-9646-1260
  • Claes, Kathleen|||0000-0003-0841-7372
  • De Leeneer, Kim
  • Meindl, Alfons
  • Gehrig, Andrea
  • Wappenschmidt, Barbara
  • Sutter, Christian|||0000-0003-4051-5888
  • Engel, Christoph
  • Niederacher, Dieter
  • Steinemann, Doris|||0000-0001-8797-0816
  • Plendl, Hansjoerg
  • Kast, Karin|||0000-0001-6531-755X
  • Rhiem, Kerstin
  • Ditsch, Nina
  • Arnold, Norbert
  • Varon-Mateeva, Raymonda
  • Schmutzler, Rita K.
  • Preisler-Adams, Sabine
  • Markov, Nadja Bogdanova
  • Wang-Gohrke, Shan
  • De Pauw, Antoine|||0000-0003-3898-073X
  • Lefol, Cédrick
  • Lasset, Christine
  • Leroux, Dominique
  • Rouleau, Etienne
  • Damiola, Francesca
  • Dreyfus, Hélène
  • Barjhoux, Laure
  • Golmard, Lisa
  • Uhrhammer, Nancy
  • Bonadona, Valérie
  • Sornin, Valérie
  • Bignon, Yves-Jean
  • Carter, Jonathan
  • Van Le, Linda
  • Piedmonte, Marion
  • DiSilvestro, Paul A.
  • Hoya, Miguel de la|||0000-0002-8113-1410
  • Caldes, Trinidad
  • Nevanlinna, Heli|||0000-0002-0916-2976
  • Aittomäki, Kristiina
  • Jager, Agnes
  • van den Ouweland, Ans M. W.
  • Kets, Carolien M.
  • Aalfs, Cora M.
  • van Leeuwen, Flora E.
  • Hogervorst, Frans B. L.
  • Meijers-Heijboer, Hanne E. J.
  • Oosterwijk, Jan C.
  • van Roozendaal, Kees E. P.
  • Rookus, Matti A.
  • Devilee, Peter|||0000-0002-8023-2009
  • van der Luijt, Rob B.
  • Olah, Edith
  • Diez, Orland|||0000-0001-7339-0570
  • Teule, Alex|||0000-0003-0028-7200
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Del Valle, Jesús|||0000-0003-3607-7045
  • Jakubowska, Anna|||0000-0002-5650-0501
  • Sukiennicki, Grzegorz
  • Gronwald, Jacek
  • Lubinski, Jan|||0000-0003-2931-3003
  • Durda, Katarzyna
  • Jaworska-Bieniek, Katarzyna
  • Agnarsson, Bjarni A.
  • Maugard, Christine
  • Amadori, Alberto
  • Montagna, Marco
  • Teixeira, Manuel R.|||0000-0002-4896-5982
  • Spurdle, Amanda B.
  • Foulkes, William|||0000-0001-7427-4651
  • Olswold, Curtis
  • Lindor, Noralane M.
  • Pankratz, Vernon S.
  • Szabo, Csilla I.
  • Lincoln, Anne
  • Jacobs, Lauren
  • Corines, Marina|||0000-0001-8472-4046
  • Robson, Mark
  • Vijai, Joseph
  • Berger, Andreas|||0000-0001-5865-6609
  • Fink-Retter, Anneliese
  • Singer, Christian F.
  • Rappaport, Christine
  • Kaulich, Daphne Geschwantler
  • Pfeiler, Georg
  • Tea, Muy-Kheng
  • Greene, Mark H.|||0000-0003-1852-9239
  • Mai, Phuong L.
  • Rennert, Gad|||0000-0002-8512-068X
  • Imyanitov, Evgeny N.
  • Mulligan, Anna Marie
  • Glendon, Gord
  • Andrulis, Irene L.|||0000-0002-4226-6435
  • Tchatchou, Sandrine
  • Toland, Amanda Ewart|||0000-0002-0271-1792
  • Pedersen, Inge Sokilde
  • Thomassen, Mads
  • Kruse, Torben A.
  • Jensen, Uffe Birk
  • Caligo, Maria|||0000-0003-0589-1829
  • Friedman, Eitan|||0000-0002-6745-1733
  • Zidan, Jamal
  • Laitman, Yael
  • Lindblom, Annika
  • Melin, Beatrice
  • Arver, Brita
  • Loman, Niklas
  • Rosenquist, Richard|||0000-0002-0211-8788
  • Olopade, Olufunmilayo I.|||0000-0002-9936-1599
  • Nussbaum, Robert L.|||0000-0003-3445-8880
  • Ramus, Susan J.|||0000-0003-0005-7798
  • Nathanson, Katherine L.|||0000-0002-6740-0901
  • Domchek, Susan M.|||0000-0002-5914-7272
  • Rebbeck, Timothy R.
  • Arun, Banu K.
  • Mitchell, Gillian
  • Karlan, Beth Y.|||0000-0002-9451-2933
  • Lester, Jenny
  • Orsulic, Sandra|||0000-0001-5119-8721
  • Stoppa-Lyonnet, Dominique
  • Thomas, Gilles
  • Simard, Jacques|||0000-0001-6906-3390
  • Couch, Fergus J.
  • Offit, Kenneth
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Chenevix-Trench, Georgia
  • Antoniou, Antonis C.
  • Mazoyer, Sylvie
  • Phelan, Catherine M.
  • Sinilnikova, Olga M.
  • Cox, David G.
Individuals carrying pathogenic mutations in the BRCA1 and BRCA2 genes have a high lifetime risk of breast cancer. BRCA1 and BRCA2 are involved in DNA double-strand break repair, DNA alterations that can be caused by exposure to reactive oxygen species, a main source of which are mitochondria. Mitochondrial genome variations affect electron transport chain efficiency and reactive oxygen species production. Individuals with different mitochondrial haplogroups differ in their metabolism and sensitivity to oxidative stress. Variability in mitochondrial genetic background can alter reactive oxygen species production, leading to cancer risk. In the present study, we tested the hypothesis that mitochondrial haplogroups modify breast cancer risk in BRCA1/2 mutation carriers. We genotyped 22,214 (11,421 affected, 10,793 unaffected) mutation carriers belonging to the Consortium of Investigators of Modifiers of BRCA1/2 for 129 mitochondrial polymorphisms using the iCOGS array. Haplogroup inference and association detection were performed using a phylogenetic approach. ALTree was applied to explore the reference mitochondrial evolutionary tree and detect subclades enriched in affected or unaffected individuals. We discovered that subclade T1a1 was depleted in affected BRCA2 mutation carriers compared with the rest of clade T (hazard ratio (HR) = 0.55; 95% confidence interval (CI), 0.34 to 0.88; P = 0.01). Compared with the most frequent haplogroup in the general population (that is, H and T clades), the T1a1 haplogroup has a HR of 0.62 (95% CI, 0.40 to 0.95; P = 0.03). We also identified three potential susceptibility loci, including G13708A/rs28359178, which has demonstrated an inverse association with familial breast cancer risk. This study illustrates how original approaches such as the phylogeny-based method we used can empower classical molecular epidemiological studies aimed at identifying association or risk modification effects. The online version of this article (doi:10.1186/s13058-015-0567-2) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comprehensive analysis of omics data identifies relevant gene networks for Attention-Deficit/Hyperactivity Disorder (ADHD)

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Soler Artigas, María|||0000-0002-3213-1107
  • Arribas, Lorena|||0000-0002-9683-9999
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Llonga, Natalia|||0000-0003-4325-6201
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent neurodevelopmental disorder that results from the interaction of both genetic and environmental risk factors. Genome-wide association studies have started to identify multiple genetic risk loci associated with ADHD, however, the exact causal genes and biological mechanisms remain largely unknown. We performed a multi-step analysis to identify and characterize modules of co-expressed genes associated with ADHD using data from peripheral blood mononuclear cells of 270 ADHD cases and 279 controls. We identified seven ADHD-associated modules of co-expressed genes, some of them enriched in both genetic and epigenetic signatures for ADHD and in biological pathways relevant for psychiatric disorders, such as the regulation of gene expression, epigenetics and immune system. In addition, for some of the modules, we found evidence of potential regulatory mechanisms, including microRNAs and common genetic variants. In conclusion, our results point to promising genes and pathways for ADHD, supporting the use of peripheral blood to assess gene expression signatures in psychiatric disorders. Furthermore, they highlight that the combination of multi-omics signals provides deeper and broader insights into the biological mechanisms underlying ADHD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Interim Results from the IMPACT Study, Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

  • Page, Elizabeth C.
  • Bancroft, Elizabeth|||0000-0002-5482-5660
  • Brook, Mark N.|||0000-0002-8969-2378
  • Assel, Melissa
  • Hassan Al Battat, Mona
  • Thomas, Sarah
  • Taylor, Natalie
  • Chamberlain, Anthony
  • Pope, Jennifer
  • Raghallaigh, Holly Ni
  • Evans, Gareth|||0000-0002-8482-5784
  • Rothwell, Jeanette
  • Maehle, Lovise
  • Grindedal, Eli Marie
  • James, Paul|||0000-0002-4361-4657
  • Mascarenhas, Lyon
  • McKinley, Joanne
  • Side, Lucy
  • Thomas, Tessy
  • van Asperen, Christi
  • Vasen, Hans|||0000-0003-2682-2603
  • Kiemeney, Lambertus A.
  • Ringelberg, Janneke
  • Jensen, Thomas Dyrso
  • Osther, Palle Jörn Sloth|||0000-0001-7962-1640
  • Helfand, Brian T.
  • Genova, Elena
  • Oldenburg, Rogier A.
  • Cybulski, Cezary|||0000-0002-2819-3057
  • Wokolorczyk, Dominika
  • Ong, Kai-Ren
  • Huber, Camilla
  • Lam, Jimmy
  • Taylor, Louise
  • Salinas, Monica
  • Feliubadaló, Lidia|||0000-0002-1736-0112
  • Oosterwijk, Jan C.
  • van Zelst-Stams, Wendy
  • Cook, Jackie
  • Rosario, Derek J.|||0000-0002-9086-3592
  • Domchek, Susan M.|||0000-0002-5914-7272
  • Powers, Jacquelyn
  • Buys, Saundra|||0000-0003-4120-5697
  • O'Toole, Karen
  • Ausems, Margreet G. E. M.
  • Schmutzler, Rita K.
  • Rhiem, Kerstin
  • Izatt, Louise|||0000-0003-1258-4843
  • Tripathi, Vishakha
  • Teixeira, Manuel R.|||0000-0002-4896-5982
  • Cardoso, Marta|||0000-0002-3633-1659
  • Foulkes, William|||0000-0001-7427-4651
  • Aprikian, Armen
  • van Randeraad, Heleen
  • Davidson, Rosemarie
  • Longmuir, Mark
  • Ruijs, Marielle W.G.
  • Helderman van den Enden, Apollonia T.J.M.
  • Adank, Muriel A.
  • Williams, Rachel|||0000-0001-6353-944X
  • Andrews, Lesley
  • Murphy, Declan G.
  • Halliday, Dorothy
  • Walker, Lisa
  • Liljegren, Annelie
  • Carlsson, Stefan
  • Azzabi, Ashraf
  • Jobson, Irene
  • Morton, Catherine
  • Shackleton, Kylie
  • Snape, Katie
  • Hanson, Helen
  • Harris, Marion
  • Tischkowitz, Marc
  • Taylor, Amy
  • Kirk, Judy
  • Susman, Rachel
  • Chen-Shtoyerman, Rakefet|||0000-0002-5055-5907
  • Spigelman, Allan
  • Pachter, Nicholas
  • Ahmed, Munaza
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Zgajnar, Janez
  • Brewer, Carole
  • Gadea, Neus|||0000-0002-6736-3979
  • Brady, Angela F.
  • Van Os, Theo
  • Gallagher, David
  • Johannsson, Oskar
  • Donaldson, Alan|||0000-0001-9193-4172
  • Barwell, Julian
  • Nicolai, Nicola|||0000-0002-5718-2699
  • Friedman, Eitan|||0000-0002-6745-1733
  • Obeid, Elias|||0000-0001-5120-9435
  • Greenhalgh, Lynn
  • Murthy, Vedang|||0000-0001-6011-9319
  • Copakova, Lucia
  • Saya, Sibel|||0000-0002-4796-6852
  • McGrath, John
  • Cooke, Peter
  • Rønlund, Karina
  • Richardson, Kate
  • Henderson, Alex
  • Teo, Soo|||0000-0002-0444-590X
  • Arun, Banu K.
  • Kast, Karin|||0000-0001-6531-755X
  • Dias, Alexander
  • Aaronson, Neil K.
  • Ardern-Jones, Audrey
  • Bangma, Chris H.
  • Castro, Elena|||0000-0002-3691-6454
  • Dearnaley, David|||0000-0002-3954-2806
  • Eccles, Diana M.|||0000-0002-9935-3169
  • Tricker, Karen
  • Eyfjord, Jorunn
  • Falconer, Alison
  • Foster, Christopher
  • Gronberg, Henrik
  • Hamdy, Freddie C.|||0000-0003-2627-2154
  • Stefansdottir, Vigdis|||0000-0003-4451-3126
  • Khoo, Vincent
  • Lindeman, Geoffrey J.|||0000-0001-9386-2416
  • Lubinski, Jan|||0000-0003-2931-3003
  • Axcrona, Karol|||0000-0002-5011-0107
  • Mikropoulos, Christos|||0000-0001-8070-2851
  • Mitra, Anita
  • Moynihan, Clare
  • Rennert, Gad|||0000-0002-8512-068X
  • Suri, Mohnish|||0000-0001-9037-701X
  • Wilson, Penny
  • Dudderidge, Tim|||0000-0001-6373-3613
  • Offman, Judith|||0000-0001-5604-1635
  • Kote-Jarai, Zsofia|||0000-0002-6329-5155
  • Vickers, Andrew J.|||0000-0003-1525-6503
  • Lilja, Hans|||0000-0001-5871-7846
  • Eeles, Rosalind|||0000-0002-3698-6241
Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-antigen (PSA) in men with germline BRCA1/2 mutations. To report the utility of PSA screening, PrCa incidence, positive predictive value of PSA, biopsy, and tumour characteristics after 3 yr of screening, by BRCA status. Men aged 40-69 yr with a germline pathogenic BRCA1/2 mutation and male controls testing negative for a familial BRCA1/2 mutation were recruited. Participants underwent PSA screening for 3 yr, and if PSA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Llonga, Natalia|||0000-0003-4325-6201
  • Arribas, Lorena|||0000-0002-9683-9999
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Demontis, Ditte|||0000-0001-9124-2766
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Børglum, Anders D.|||0000-0001-8627-7219
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Soler Artigas, María|||0000-0002-3213-1107
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

The negative impact of neurodevelopmental disorders and multiple co-occurring conditions on academic performance of school-age children and adolescents

  • Autet, Aurea
  • Pagespetit, Èlia
  • Andreu, Maria
  • Pagerols, Mireia
  • Prat, Raquel
  • Español Martin, Gemma
Academic performance; Co-occurring conditions; Neurodevelopmental disorders, Rendiment acadèmic; Condicions concurrents; Trastorns del neurodesenvolupament, Rendimiento académico; Condiciones concurrentes; Trastornos del neurodesarrollo, Students with neurodevelopmental disorders (ND) are at risk for academic impairment. However, the pervasive co-occurrence among these conditions has rarely been considered when evaluating this association. This study examined whether intellectual disabilities (ID), communication disorders, autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), specific learning disorder (SLD), and motor disorders were related to academic outcomes. Parents and teachers completed standardized screening instruments for mental health problems and learning difficulties. Children who screened positive were interviewed for diagnostic confirmation according to the Diagnostic and Statistical Manual of Mental Disorders, while students who screened negative served as controls. Academic performance across multiple subjects was obtained from school records. The final sample comprised 9018 participants aged 5-17. Mixed-effects ordinal logistic regression models determined the independent and combined effects of ND on academic performance, adjusting for background and coexisting conditions. When examined separately, each diagnostic category was significantly associated with lower marks in all educational outcomes, even after adjusting for sociodemographic and school-related factors. However, when the influence of neurodevelopmental co-occurrence was controlled for, ID emerged as the strongest predictor of poor academic performance, followed by ADHD, SLD, and communication disorders. ASD and motor disorders were only associated with lower marks in arts and physical education. Furthermore, youth with coexisting conditions were at higher risk for academic impairment across all subjects. These findings highlight the need for early diagnosis and targeted interventions to address the specific educational needs of students with ND. Likewise, co-occurring diagnoses should be actively sought to avoid disadvantaging children with multiple disorders., This work was funded by Fundació “la Caixa” (LCR/PR/PR20/51150021), Diputació de Barcelona (PR(AG)72-2012 (2016/011627)), Pla Estratègic de Recerca i Innovació en Salut (SLT006/17/00285), Fundació La Marató de TV3 (202228-30-31), Fondo de Investigaciones Sanitarias (PI23/00026, PI23/00040), Agència de Gestió d’Ajuts Universitaris i de Recerca (DI-2024-00034), Fundació d’Investigació Salut i Progrés (FISP), and the Department of Health (Generalitat de Catalunya).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment

  • Bosch, Rosa
  • Carabí-Gassol, Pau
  • MACÍAS CHIMBORAZO, VALERIA
  • Español Martin, Gemma
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Attention-deficit/hyperactivity disorder; Autism spectrum disorder; School performance, Trastorn per dèficit d'atenció i hiperactivitat; Trastorn de l'espectre autista; Rendiment escolar, Trastorno por déficit de atención e hiperactividad; Trastorno del espectro autista; Rendimiento escolar, Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are strongly associated with educational attainment (EA), but little is known about their genetic relationship with school performance and whether these links are explained, in part, by the genetic liability of EA. Here, we aim to dissect the polygenic contribution of ADHD and ASD to school performance, early manifestation of psychopathology and other psychiatric disorders and related traits by their relationship with EA. To do so, we tested the association of polygenic scores for EA, ADHD and ASD with school performance, assessed whether the contribution of the genetic liability of ADHD and ASD to school performance is influenced by the genetic liability of EA, and evaluated the role of EA in the genetic overlap between ADHD and ASD with early manifestation of psychopathology and other psychiatric disorders and related traits in a sample of 4,278 school-age children. The genetic liability for ADHD and ASD dissected by their relationship with EA show differences in their association with school performance and early manifestation of psychopathology, partly mediated by ADHD and ASD symptoms. Genetic variation with concordant effects in ASD and EA contributes to better school performance, while the genetic variation with discordant effects in ADHD or ASD and EA is associated with poor school performance and higher rates of emotional and behavioral problems. Our results strongly support the usage of the genetic load for EA to dissect the genetic and phenotypic heterogeneity of ADHD and ASD, which could help to fill the gap of knowledge of mechanisms underlying educational outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404, PI23/00026 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Network Center for Biomedical Research (CIBER) to J.C.D.; the European Regional Development Fund (ERDF); the ECNP Network ‘ADHD across the Lifespan’; “la Marató de TV3” (202228-30 and 202228-31), “Fundació ‘la Caixa’, Diputació de Barcelona, Pla Estratègic de Recerca i Innovació en Salut” (PERISSLT006/17/285); “Fundació Privada d’Investigació Sant Pau” (FISP); and Ministry of Health of Generalitat de Catalunya.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

  • Coignard, Juliette
  • Beesley, Jonathan
  • O'Mara, Tracy A.
  • Diez Gibert, Orland
  • Lopez Fernandez, Adrià
  • Dennis, Joe
  • Tyrer, Jonathan
  • Lush, Michael
Càncer de mama; Genètica del càncer; Factors de risc, Cáncer de mama; Genética del cáncer; Factores de riesgo, Breast cancer; Cancer genetics; Risk factors, Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10−8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores

  • GRAU-LÓPEZ, LARA
  • Daigre, Constanza
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Heterogeneity; Substance use disorder; Genome, Heterogeneidad; Trastorno por consumo de sustancias; Genoma, Heterogeneïtat; Trastorn per consum de substàncies; Genoma, Substance use disorder (SUD) is a global health problem with a significant impact on individuals and society. The presentation of SUD is diverse, involving various substances, ages at onset, comorbid conditions, and disease trajectories. Current treatments for SUD struggle to address this heterogeneity, resulting in high relapse rates. SUD often co-occurs with other psychiatric and mental health-related conditions that contribute to the heterogeneity of the disorder and predispose to adverse disease trajectories. Family and genetic studies highlight the role of genetic and environmental factors in the course of SUD, and point to a shared genetic liability between SUDs and comorbid psychopathology. In this study, we aimed to disentangle SUD heterogeneity using a deeply phenotyped SUD cohort and polygenic scores (PGSs) for psychiatric disorders and related traits. We explored associations between PGSs and various SUD-related phenotypes, as well as PGS-environment interactions using information on lifetime emotional, physical, and/or sexual abuse. Our results identify clusters of individuals who exhibit differences in their phenotypic profile and reveal different patterns of associations between SUD-related phenotypes and the genetic liability for mental health-related traits, which may help explain part of the heterogeneity observed in SUD. In our SUD sample, we found associations linking the genetic liability for attention-deficit hyperactivity disorder (ADHD) with lower educational attainment, the genetic liability for post-traumatic stress disorder (PTSD) with higher rates of unemployment, the genetic liability for educational attainment with lower rates of criminal records and unemployment, and the genetic liability for well-being with lower rates of outpatient treatments and fewer problems related to family and social relationships. We also found evidence of PGS-environment interactions showing that genetic liability for suicide attempts worsened the psychiatric status in SUD individuals with a history of emotional physical and/or sexual abuse. Collectively, these data contribute to a better understanding of the role of genetic liability for mental health-related conditions and adverse life experiences in SUD heterogeneity., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840 and 2021-SGR-01093), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to M.S.A, RYC2021-031324-I to J.C.D and PID2021-1277760B-I100 to B.C. and N.F-C.), the Ministry of Health, Social Services and Equality (PNSD-2020I042 to N.F-C.), the Network Center for Biomedical Research (CIBER) to J.C.D., the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’, “Fundació La Marató de TV3” (202228-30, 202228-31 and 202218-31) and ICREA Academia 2021.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Arribas, Lorena
  • Demontis, Ditte
  • Cabana-Dominguez, Judit
  • Llonga, Natalia
  • Alemany, Silvia
  • Vilar-Ribo, Laura
  • Fadeuilhe, Christian
  • Corrales, Montserrat
  • Richarte, Vanesa
  • Soler Artigas, María
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Transcriptomic risk scores; Attention deficit and hyperactivity disorder, Puntuaciones de riesgo transcriptómico; Trastorno por déficit de atención e hiperactividad, Puntuació de risc transcriptòmic; Trastorn per dèficit d'atenció i hiperactivitat, Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III and co-funded by the European Union Found: Fondo Social Europeo Plus (FSE+) (P19/01224, PI20/00041, PI22/00464 and FI18/00285 to LVR, CP22/00128 to MSA and CP22/00026 to SA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD), the Network Center for Biomedical Research (CIBER) to JCD, the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’ and the “la Marató de TV3” (202228-30 and 202228-31). ADB was supported by grants from the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003) and NIH/NIMH (1R01MH124851-01). DD was supported by the Novo Nordisk Foundation (NNF20OC0065561) and the Lundbeck Foundation (R344-2020-1060).